基于CRISPR的IRF9的功能分析揭示了dSRNA刺激的先天免疫通路的明显调节
Grace E Schmidt1, Evelyn A Weaver1, Tae H Kim2
1Department of Animal Science, The Pennsylvania State University. AVBS Building, University Park, PA, 16802, United States.
Developmental and comparative immunology
|February 27, 2026
概括
干扰素调节因子9 (IRF9) 在天生的免疫力中起着独特的作用,与其哺乳动物对应物不同. 抑制IRF9会影响I型干扰素通路,突出显示它在禽类抗病毒反应中的特殊功能.
科学领域:
- 鸟类免疫学 鸟类免疫学
- 天生的免疫反应.
- 分子生物学分子生物学
背景情况:
- 的免疫系统与哺乳动物模型不同,具有减少的基因谱,但仍然保持强大的免疫反应.
- 干扰素调节因子9 (IRF9) 对于哺乳动物的I型干扰素 (IFN) 途径调节至关重要,控制许多抗病毒基因.
- 一个假定的IRF9基因已被确定,促使对其功能进行调查.
研究的目的:
- 调查假定IRF9在先天免疫反应中的功能作用.
- 在I型干扰素信号传递的背景下阐明IRF9的调节机制.
主要方法:
- 利用基于CRISPR的转录模拟平台来抑制的IRF9表达.
- 分析了在不同时间点 (0,0.5,1,6小时) 用双链RNA刺激压抑细胞的转录组.
- 进行基因组丰富分析以确定受影响的生物通路.
主要成果:
- 抑制IRF9导致了参与I型IFN反应调节的途径的丰富,包括RIG-I类和Toll类受体途径.
- 同时抑制IRF7和激活IRF9并没有恢复下游IFN刺激基因的表达.
- 这些发现表明,与哺乳动物IRF9.9相比,肉IRF9具有不同的调节作用.
结论:
- IRF9在I型干扰素反应中表现出独特的调节功能,与其哺乳动物同类物不同.
- 类IRF的功能性特征是必要的,以准确地分类和了解禽类免疫力.
- 这项研究强调了对干扰素调节因子的基于证据的功能分类的需要.
相关概念视频
Experimental RNAi
8.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.1K
CRISPR and crRNAs
19.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.4K
CRISPR
58.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.3K
The Antiviral System of Bacteria and Archaea: CRISPR
830
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
830
CRISPR/Cas9 Genome Editing
2.2K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.2K
RNA Interference
28.3K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.3K


